As of October 2024, the U.S. stock market is experiencing a notable upswing, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs amid their longest winning streaks of the year. This positive momentum highlights the potential for investors to explore stocks that may still be trading below their intrinsic value despite broader market gains. Identifying such undervalued stocks requires careful analysis of financial health and growth prospects in relation to current economic conditions, which can provide opportunities for strategic investment decisions.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Silicon Motion Technology (NasdaqGS:SIMO) | $55.94 | $107.01 | 47.7% |
MidWestOne Financial Group (NasdaqGS:MOFG) | $29.69 | $57.34 | 48.2% |
Associated Banc-Corp (NYSE:ASB) | $22.85 | $43.82 | 47.9% |
Atlanticus Holdings (NasdaqGS:ATLC) | $37.39 | $72.49 | 48.4% |
Avidbank Holdings (OTCPK:AVBH) | $19.60 | $37.73 | 48.1% |
EVERTEC (NYSE:EVTC) | $33.28 | $66.37 | 49.9% |
Vitesse Energy (NYSE:VTS) | $25.00 | $49.16 | 49.1% |
AeroVironment (NasdaqGS:AVAV) | $216.97 | $416.68 | 47.9% |
Vasta Platform (NasdaqGS:VSTA) | $2.5568 | $4.87 | 47.5% |
Viking Holdings (NYSE:VIK) | $38.97 | $74.65 | 47.8% |
Click here to see the full list of 188 stocks from our Undervalued US Stocks Based On Cash Flows screener.
Let's uncover some gems from our specialized screener.
Overview: Repligen Corporation develops and commercializes bioprocessing technologies and systems for biological drug manufacturing globally, with a market cap of approximately $8.23 billion.
Operations: The company's revenue is primarily derived from its Medical Products segment, which generated $602.35 million.
Estimated Discount To Fair Value: 22%
Repligen is trading at US$146.95, below its estimated fair value of US$188.49, indicating potential undervaluation based on cash flows. Despite a challenging year with reduced net income and earnings per share, the company reaffirmed its 2024 revenue guidance between $627 million and $642 million. Analysts expect the stock price to rise by 30.5%, supported by forecasted annual profit growth above market averages over the next three years.
Overview: Crown Holdings, Inc., along with its subsidiaries, operates in the packaging industry both in the United States and internationally, with a market cap of $11.55 billion.
Operations: The company's revenue segments include Americas Beverage at $5.21 billion, European Beverage at $2.01 billion, Transit Packaging at $2.19 billion, and Asia Pacific at $1.17 billion.
Estimated Discount To Fair Value: 39.2%
Crown Holdings is trading at US$97.75, significantly below its estimated fair value of US$160.89, suggesting potential undervaluation based on cash flows. Despite a challenging financial period with a net loss of US$175 million in Q3 2024 and reduced profit margins, the company raised its full-year earnings guidance to between $6.25 and $6.35 per share. Forecasted annual earnings growth exceeds market averages, although high debt levels remain a concern.
Overview: Flutter Entertainment plc is a sports betting and gaming company with operations in the United Kingdom, Ireland, Australia, the United States, Italy, and internationally, and has a market cap of $41.31 billion.
Operations: The company's revenue segments include $5.25 billion from the US, $3.31 billion from the UK and Ireland, $1.39 billion from Australia, and $2.93 billion internationally.
Estimated Discount To Fair Value: 30.4%
Flutter Entertainment is trading at US$232.33, below its estimated fair value of US$333.66, indicating undervaluation based on cash flows. The company forecasts revenue growth of 12.1% annually, outpacing the US market average, and expects earnings to grow by a substantial 56.25% per year as it becomes profitable in three years. Recent developments include a significant share buyback program worth up to $5 billion and ongoing acquisition discussions in Italy and Brazil.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqGS:RGEN NYSE:CCK and NYSE:FLUT.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.